HUT vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

HUT

59.6
AI Score
VS
HUT Wins

HIVE

48.2
AI Score

Investment Advisor Scores

HUT

60score
Recommendation
HOLD

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUT HIVE Winner
Forward P/E 84.7458 62.8931 HIVE
PEG Ratio 0 0 Tie
Revenue Growth 81.4% 73.5% HUT
Earnings Growth 6006.8% -99.9% HUT
Tradestie Score 59.6/100 48.2/100 HUT
Profit Margin -188.6% -98.5% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HUT 1M: -31.3% · 3M: -23.2% HIVE 1M: -4.7% · 3M: -21.3%

Current Technical Phase

HUT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.6%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $80.86

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

Fundamentals Snapshot

Metric HUT HIVE
Market Cap
Forward P/E -15.6 -5.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.8% 0.7%
Gross Margin 0.6% 0.4%
Operating Margin -2.8% -0.6%
EPS -5.83 -1.54
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HUT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.